This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Teva Hungary Chooses Magic Xpi Integration Platform To Improve Business Performance

OR YEHUDA, Israel, September 19, 2012 /PRNewswire/ --

Magic Software Enterprises Ltd. (NASDAQ: MGIC), a global provider of software platforms for enterprise mobility, cloud applications, and business integration, announced today that Teva Hungary has adopted Magic xpi Integration Platform to update and enhance its customer ordering process.

Teva Hungary, which has been using Magic's technology for many years to manage all its operational processes, chose the Magic xpi code-free business integration platform to improve the efficiency, security, and performance of its electronic customer ordering process.

"We were encountering many difficulties in implementing our electronic ordering system, in particular with regard to error-handling and order clarification. We solved these problems with Magic xpi, which offered the ideal solution for integrating all our logistics systems into a single, unified solution that truly works," said Mr. Janos Gorbe, Project Manager at Teva Hungary.

Commenting on the new deal, Yoram Aharon, CEO of Magic Israel, said: "We are very pleased with Teva Hungary's decision to continue using Magic's technology. Magic xpi offers fast and cost-effective integration, providing enormous added value to our customers."

About Magic Software Enterprises

Magic Software Enterprises (NASDAQ: MGIC) empowers customers and partners around the globe with smarter technology that provides a multichannel user experience of enterprise logic and data.

For more information, visit

About Teva Hungary

The activities of Teva Hungary Ltd. include marketing and sales. Manufacturing is performed at various sites of Teva Pharmaceutical Works Ltd.

Teva's extremely broad product range in many therapeutic areas, such as cardiovascular, gastrointestinal, and oncologic diseases, enables the company to achieve its goal of making high-quality generic drugs available to all.

For more information, visit

Except for any historical information contained herein, matters discussed in this press release might include forward-looking statements that involve a number of risks and uncertainties. Regarding any financial statements, actual results might vary significantly based upon a number of factors including, but not limited to, risks in product and technology development, market acceptance of new products and continuing product conditions, both locally and abroad, release and sales of new products by strategic resellers and customers, and other risk factors detailed in Magic's most recent annual report and other filings with the Securities and Exchange Commission.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.86 -0.15%
FB $100.67 0.92%
GOOG $690.64 1.20%
TSLA $155.77 -4.20%
YHOO $27.08 -3.20%


Chart of I:DJI
DOW 16,005.95 -21.10 -0.13%
S&P 500 1,837.86 -15.58 -0.84%
NASDAQ 4,225.5040 -58.2490 -1.36%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs